WillItSurvive
Retail and consumer conglomerates · India

Dabur India

dabur.com ↗

141-year-old Indian FMCG maker of ayurvedic food, health and personal care products.

Hard to displace
Assessed 25 July 2026 · Evidence as of 25 July 2026
Strong structural protection; the business model survives ai pressure.
On the recordSince 25 July 2026 · Checkable from July 29, 2026 · Every call on the record Checkpoint: Q1 FY27 earnings test raised 'low double-digit' growth guidance
The call

Dabur keeps growing modestly on trust and reach, while Patanjali and quick-commerce chip at the edges of its home turf.

It is hard to replace because of its long history, trusted brand name, and deep network of stores and distributors, though rivals like Patanjali have proven they can grab market share with similar Ayurvedic products. The real threat is that online shopping and fast delivery services are making old-fashioned distribution networks less important, so if Dabur cannot sell successfully through these new channels while keeping profits healthy, its fortress could weaken.

Why
01
AI pressure: None apparent. AI doesn't threaten shelf space directly, but AI-curated D2C and quick-commerce apps change how shoppers find rivals like Patanjali. Could AI do the core job? Unlikely.
02
Bigger players: Patanjali Ayurved. Patanjali has taken ayurvedic share since 2006 with ₹10,664 crore FY2022 revenue, hitting Dabur's Chyawanprash and honey turf directly. Could a giant copy it? Probably.
03
What protects it. Ayurvedic brand trust, GMP manufacturing licenses, and rural distribution reaching 8 of 10 Indian homes.
What would change this call
Dabur's Q1 FY27 results (due ~July 2026) versus its raised low-double-digit guidance. Shows whether core India FMCG volume growth is holding or slipping.
FDA Dadra plant import alert remediation and whether it spreads to other Dabur plants. Indicates whether regulatory/quality moat is weakening.
Chyawanprash and honey category share data from Nielsen or company commentary vs Patanjali/Emami. Would confirm whether rivals are actually taking crown-jewel SKU share.
Key numbers
  • FY26 revenue up 5.17% to Rs 13,792 crore (2026-05-08)
  • Market cap $9B, down 11.9% YoY (2026-06-28)
  • Patanjali FY2022 revenue Rs 10,664 crore (2022)
Named risks
  • FDA import alert on Dadra plant threatens US exports pending remediation. Severity: high
  • Emami trade-dress litigation could restrict Cool King product line. Severity: medium
  • Quick-commerce and D2C channel shift may erode traditional rural distribution moat. Severity: medium
  • Middle East tensions and freight costs slowed international growth to 2.5% in Q4 FY26. Severity: medium
  • Permanent headcount decline of 10.7% in FY26 may signal ongoing cost pressure. Severity: low
Rivals, as read in July 2026
RivalDirectionEvidence
Patanjali AyurvedcontestingLive Chyawanprash advertising litigation, Delhi HC update Feb 23, 2026; Patanjali ~₹10,664 cr FY2022 revenue
Emamilosing toDelhi HC ruled against Dabur's Cool King trade dress Jan 2026, appeal judgment May 22, 2026
Hindustan UnilevercontestingHUL's Lever Ayush competes in naturals but hasn't dislodged Dabur's flagship SKUs
Colgate-PalmolivecontestingColgate's Vedshakti herbal toothpaste took some share without unseating Dabur Red
Marico and Tata Consumer Productsgaining onBoth added headcount in FY26 while Dabur and HUL shrank staff, reported July 12, 2026
Questions people ask
Is Dabur India profitable in 2026?
Yes. Dabur's FY2025-26 consolidated net profit rose 7.37% YoY to ₹1,868.69 crore on total income of ₹13,792.34 crore, up 5.17%, as reported May 8, 2026. Q4 FY26 profit alone jumped about 15% YoY to ₹362-369 crore.
Is Dabur India doing layoffs?
Dabur's permanent workforce shrank to 4,770 as of March 31, 2026 from 5,343 a year earlier, a 10.7% decline, even as median pay rose 7.7%, per its FY26 statutory disclosure reported July 12, 2026. This mirrors sector-wide FMCG belt-tightening.
Could AI replace Dabur India?
No. Dabur's moat is 141 years of Ayurvedic brand trust, GMP manufacturing licenses, and distribution reaching a company-claimed 8 of 10 Indian households (May 4, 2026). AI is only used internally for marketing content, reporting, and search automation, not for core physical retail distribution.
Who is Dabur India's biggest competitor?
Patanjali Ayurved, founded 2006, reported roughly ₹10,664 crore in FY2022 revenue and remains in active comparative-advertising litigation with Dabur over Chyawanprash claims, with a Delhi High Court update dated February 23, 2026.
Who owns Dabur India?
The Burman family, Dabur's founding promoters, holds a 66.24% stake per the most recent disclosed figures. Dabur has been publicly traded on the BSE (scrip 500096) and NSE (DABUR) for decades, with professional management separated from family control since 1998.
Is Dabur India stock up or down in 2026?
Down. Dabur's market cap was about ₹751.98 billion (roughly $9 billion) as of June 28, 2026, down approximately 11.9% year-over-year, with shares trading well below their all-time high of ₹672 in a 52-week range of ₹401-577.
Timeline
  • 2026-07-12Permanent headcount reported down to 4,770 from 5,343 a year earlier
  • 2026-06-11FDA import alert issued on Dabur's Dadra and Nagar Haveli manufacturing plant
  • 2026-05-22Delhi High Court delivered appeal judgment in Emami trade-dress case
  • 2026-05-07Dabur raised FY27 revenue growth guidance to low double-digit
  • 2026-05-04Q4 FY26 results released, net profit up about 15% YoY
  • 2026-03-13NCLT approved merger scheme for Sesa Care acquisition
  • 2026-03-01Dabur Ventures made first investment, ₹60 crore stake in RAS Beauty
  • 2026-02-11Groundbreaking on ₹400 crore Tamil Nadu manufacturing facility
  • 2025-07-30Q1 FY26 results released, net profit up about 3% YoY
  • 2025-06-17Launched Siens by Dabur, D2C nutraceutical brand
Revision history
25 July 2026
First assessed. Hard to displace. The text above is fixed as of this date and is not edited afterwards.
In the same band
Costco WholesaleHome DepotCoca-Cola
More in Retail and consumer conglomerates →
Sources